av/unicycive-therapeutics--big.svg

COM:UNICYCIVE

Unicycive

  • Stock

Last Close

0.53

22/11 21:00

Market Cap

41.21M

Beta: -

Volume Today

841.15K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
average payables
253K
-
463K
83.00%
817K
76.46%
856.50K
4.83%
average receivables
book value per share
-0.06
-
-0.31
410.73%
1.41
553.33%
-0.03
102.19%
-0.16
401.54%
capex per share
-0.00
-
-0.00
94.65%
-0.00
268.15%
capex to depreciation
-2.23
-
-0.01
99.44%
-0.04
240.14%
capex to operating cash flow
0.01
-
0.00
97.46%
0.00
413.62%
capex to revenue
-0.00
-
-0.02
745.33%
cash per share
0.00
-
1.42
-
0.03
97.87%
0.40
1,208.23%
days of inventory on hand
days payables outstanding
1.06K
-
days sales outstanding
debt to assets
24.21
-
12.32
49.10%
0.02
99.87%
0.06
236.92%
0.06
3.90%
debt to equity
-0.52
-
-0.94
80.88%
0.02
101.97%
-0.33
1,891.79%
-0.21
35.99%
dividend yield
0.04
-
earnings yield
-0.03
-
-0.06
84.00%
-0.44
655.81%
-2.22
402.59%
-1.43
35.43%
enterprise value
72.93M
-
45.40M
37.75%
7.78M
82.86%
7.83M
0.67%
12.40M
58.38%
enterprise value over ebitda
-37.15
-
-22.47
39.51%
-0.87
96.14%
-0.43
49.94%
-0.61
39.54%
ev to operating cash flow
-62.01
-
-31.11
49.83%
-1.35
95.66%
-0.50
62.91%
-0.68
35.58%
ev to sales
8.23
-
18.37
123.15%
free cash flow per share
-0.08
-
-0.17
109.71%
-0.50
191.81%
-1.04
109.42%
-0.75
28.28%
free cash flow yield
-0.02
-
-0.03
109.71%
-0.24
608.27%
-1.93
698.89%
-0.86
55.37%
graham net net
-0.06
-
-0.34
447.26%
1.23
465.84%
-0.19
115.32%
-0.34
80.00%
graham number
0.47
-
1.43
206.55%
5.38
275.72%
0.91
83.01%
2.08
128.11%
income quality
0.54
-
0.64
18.64%
0.58
10.66%
0.87
50.54%
0.60
30.94%
intangibles to total assets
0
-
0
0
0
0
interest coverage
-14.12
-
-8.28
41.38%
-14.29
72.67%
-3.01K
20,947.60%
253.34
108.42%
interest debt per share
0.04
-
0.32
678.28%
0.08
75.12%
0.01
86.63%
0.03
177.83%
inventory turnover
invested capital
-0.52
-
-0.94
80.88%
0.02
101.97%
-0.33
1,891.79%
-0.21
35.99%
market cap
72.48M
-
42.88M
40.84%
24.05M
43.91%
8.13M
66.19%
21.29M
161.88%
net current asset value
-884K
-
-2.67M
202.15%
16.15M
704.68%
-640K
103.96%
-4.60M
618.91%
net debt to ebitda
-0.23
-
-1.24
449.00%
1.81
245.65%
0.02
99.08%
0.43
2,510.74%
net income per share
-0.16
-
-0.29
84.00%
-0.91
211.39%
-1.20
31.75%
-1.24
3.75%
operating cash flow per share
-0.08
-
-0.17
109.71%
-0.49
190.35%
-1.04
110.44%
-0.75
28.32%
payables turnover
0.35
-
receivables turnover
research and ddevelopement to revenue
13.08
-
19.11
46.17%
return on tangible assets
-121.26
-
-12.29
89.86%
-0.57
95.39%
-6.41
1,030.11%
-2.15
66.42%
revenue per share
0.06
-
0.03
56.45%
roe
2.61
-
0.94
63.97%
-0.64
168.69%
38.76
6,110.02%
8.02
79.31%
roic
4.93
-
14.25
189.28%
-0.56
103.91%
115.76
20,869.74%
8.20
92.91%
sales general and administrative to revenue
6.91
-
12.66
83.37%
shareholders equity per share
-0.06
-
-0.31
410.73%
1.41
553.33%
-0.03
102.19%
-0.16
401.54%
stock based compensation to revenue
1.10
-
2.62
137.78%
tangible asset value
-884K
-
-2.67M
202.15%
16.48M
717.15%
-466K
102.83%
-3.81M
717.38%
tangible book value per share
-0.06
-
-0.31
410.73%
1.41
553.33%
-0.03
102.19%
-0.16
401.54%
working capital
-884K
-
-2.67M
202.15%
16.31M
710.48%
-640K
103.92%
-4.13M
546.09%

All numbers in (except ratios and percentages)